Found: 25
Select item for more details and to access through your institution.
High Efficacy and Drug Synergy of HDAC6-Selective Inhibitor NN-429 in Natural Killer (NK)/T-Cell Lymphoma.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 11, p. 1321, doi. 10.3390/ph15111321
- By:
- Publication type:
- Article
Dynamic Reprogramming of Signaling Upon Met Inhibition Reveals a Mechanism of Drug Resistance in Gastric Cancer.
- Published in:
- Science Signaling, 2014, v. 7, n. 322, p. 1, doi. 10.1126/scisignal.2004839
- By:
- Publication type:
- Article
Phenotypic Screening of Histone Deacetylase (HDAC) Inhibitors against Schistosoma mansoni.
- Published in:
- ChemMedChem, 2022, v. 17, n. 18, p. 1, doi. 10.1002/cmdc.202100622
- By:
- Publication type:
- Article
Artificially Induced Protein-Membrane Anchorage with Cholesterol-Based Recognition Agents as a New Therapeutic Concept.
- Published in:
- Angewandte Chemie, 2011, v. 123, n. 28, p. 6372, doi. 10.1002/ange.201102486
- By:
- Publication type:
- Article
Mutations in UBA3 Confer Resistance to the NEDD8-Activating Enzyme Inhibitor MLN4924 in Human Leukemic Cells.
- Published in:
- PLoS ONE, 2014, v. 9, n. 4, p. 1, doi. 10.1371/journal.pone.0093530
- By:
- Publication type:
- Article
Oncogenic Kinase Cascades Induce Molecular Mechanisms That Protect Leukemic Cell Models from Lethal Effects of De Novo dNTP Synthesis Inhibition.
- Published in:
- Cancers, 2021, v. 13, n. 14, p. 3464, doi. 10.3390/cancers13143464
- By:
- Publication type:
- Article
Targeting STAT3 and STAT5 in Cancer.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
STAT5 is Expressed in CD34+/CD38− Stem Cells and Serves as a Potential Molecular Target in Ph-Negative Myeloproliferative Neoplasms.
- Published in:
- Cancers, 2020, v. 12, n. 4, p. 1021, doi. 10.3390/cancers12041021
- By:
- Publication type:
- Article
Structural Implications of STAT3 and STAT5 SH2 Domain Mutations.
- Published in:
- Cancers, 2019, v. 11, n. 11, p. 1757, doi. 10.3390/cancers11111757
- By:
- Publication type:
- Article
PI3k and Stat3: Oncogenes that are Required for Gap Junctional, Intercellular Communication.
- Published in:
- Cancers, 2019, v. 11, n. 2, p. 167, doi. 10.3390/cancers11020167
- By:
- Publication type:
- Article
Understanding Protein-Protein Interactions: Essential Players in (Patho)physiology (Part 1).
- Published in:
- 2016
- By:
- Publication type:
- Editorial
Progress towards direct inhibitors of Stat5 protein.
- Published in:
- Hormone Molecular Biology & Clinical Investigation, 2012, v. 10, n. 2, p. 281, doi. 10.1515/hmbci-2012-0009
- By:
- Publication type:
- Article
Chronic Inhibition of STAT3/STAT5 in Treatment-Resistant Human Breast Cancer Cell Subtypes: Convergence on the ROS/SUMO Pathway and Its Effects on xCT Expression and System xc- Activity.
- Published in:
- PLoS ONE, 2016, v. 11, n. 8, p. 1, doi. 10.1371/journal.pone.0161202
- By:
- Publication type:
- Article
Understanding Protein-Protein Interactions: Essential Players in (Patho)physiology (Part 2).
- Published in:
- 2016
- By:
- Publication type:
- Editorial
Disarming an Electrophilic Warhead: Retaining Potency in Tyrosine Kinase Inhibitor (TKI)-Resistant CML Lines While Circumventing Pharmacokinetic Liabilities.
- Published in:
- ChemMedChem, 2016, v. 11, n. 8, p. 850, doi. 10.1002/cmdc.201600021
- By:
- Publication type:
- Article
Inside Cover: Disarming an Electrophilic Warhead: Retaining Potency in Tyrosine Kinase Inhibitor (TKI)-Resistant CML Lines While Circumventing Pharmacokinetic Liabilities (ChemMedChem 8/2016).
- Published in:
- ChemMedChem, 2016, v. 11, n. 8, p. 731, doi. 10.1002/cmdc.201600185
- By:
- Publication type:
- Article
Antagonism of the Stat3-Stat3 Protein Dimer with Salicylic Acid Based Small Molecules.
- Published in:
- ChemMedChem, 2011, v. 6, n. 8, p. 1459, doi. 10.1002/cmdc.201100194
- By:
- Publication type:
- Article
Molecular Approaches towards the Inhibition of the Signal Transducer and Activator of Transcription 3 (Stat3) Protein.
- Published in:
- ChemMedChem, 2008, v. 3, n. 8, p. 1159, doi. 10.1002/cmdc.200800123
- By:
- Publication type:
- Article
Cover Picture: Molecular Approaches towards the Inhibition of the Signal Transducer and Activator of Transcription 3 (Stat3) Protein (ChemMedChem 8/2008).
- Published in:
- ChemMedChem, 2008, v. 3, n. 8, p. 1145, doi. 10.1002/cmdc.200890030
- By:
- Publication type:
- Article
Disruption of Transcriptionally Active Stat3 Dimers with Non-phosphorylated, Salicylic Acid-Based Small Molecules: Potent in vitro and Tumor Cell Activities.
- Published in:
- ChemBioChem, 2009, v. 10, n. 12, p. 1959, doi. 10.1002/cbic.200900172
- By:
- Publication type:
- Article
Inside Cover: Disruption of Transcriptionally Active Stat3 Dimers with Non-phosphorylated, Salicylic Acid-Based Small Molecules: Potent in vitro and Tumor Cell Activities (ChemBioChem 12/2009).
- Published in:
- ChemBioChem, 2009, v. 10, n. 12, p. 1906, doi. 10.1002/cbic.200990048
- By:
- Publication type:
- Article
Targeting Protein-Protein Interactions: Suppression of Stat3 Dimerization with Rationally Designed Small-Molecule, Nonpeptidic SH2 Domain Binders.
- Published in:
- ChemBioChem, 2008, v. 9, n. 17, p. 2800, doi. 10.1002/cbic.200800291
- By:
- Publication type:
- Article
Artificially Induced Protein-Membrane Anchorage with Cholesterol-Based Recognition Agents as a New Therapeutic Concept.
- Published in:
- Angewandte Chemie International Edition, 2011, v. 50, n. 28, p. 6248, doi. 10.1002/anie.201102486
- By:
- Publication type:
- Article
Effect of caveolin-1 on Stat3-ptyr705 levels in breast and lung carcinoma cells.
- Published in:
- Biochemistry & Cell Biology, 2019, v. 97, n. 5, p. 638, doi. 10.1139/bcb-2018-0367
- By:
- Publication type:
- Article
Molecular disruption of oncogenic signal transducer and activator of transcription 3 (STAT3) protein.
- Published in:
- Biochemistry & Cell Biology, 2009, v. 87, n. 6, p. 825, doi. 10.1139/O09-044
- By:
- Publication type:
- Article